Chemokines and their receptors in the brain: pathophysiological roles in ischemic brain injury.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 14607260)

Published in Life Sci on December 05, 2003

Authors

Masabumi Minami1, Masamichi Satoh

Author Affiliations

1: Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 606-8501, Kyoto, Japan.

Articles citing this

Mechanisms of ischemic brain damage. Neuropharmacology (2008) 2.40

The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation (2010) 1.54

Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells. Blood (2006) 1.30

CD36 in the periphery and brain synergizes in stroke injury in hyperlipidemia. Ann Neurol (2012) 1.27

Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease. Clin Exp Nephrol (2008) 1.14

Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke. PLoS One (2013) 1.08

Human microglia transplanted in rat focal ischemia brain induce neuroprotection and behavioral improvement. PLoS One (2010) 1.07

Rational modulation of the innate immune system for neuroprotection in ischemic stroke. Front Neurosci (2015) 1.02

Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats. Clin Exp Immunol (2004) 0.98

Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices. J Neurochem (2010) 0.98

Minocycline reduces neuronal death and attenuates microglial response after pediatric asphyxial cardiac arrest. J Cereb Blood Flow Metab (2009) 0.95

Inflammation in adult and neonatal stroke. Clin Neurosci Res (2006) 0.94

The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain. J Cereb Blood Flow Metab (2010) 0.92

Elevated plasma MCP-1 concentration following traumatic brain injury as a potential "predisposition" factor associated with an increased risk for subsequent development of Alzheimer's disease. J Alzheimers Dis (2012) 0.88

Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice. Korean J Physiol Pharmacol (2011) 0.84

Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective. J Aging Res (2011) 0.83

A microarray study of middle cerebral occlusion rat brain with acupuncture intervention. Evid Based Complement Alternat Med (2015) 0.81

Chemokines and neurodegeneration in the early stage of experimental ischemic stroke. Mediators Inflamm (2013) 0.80

The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics (2014) 0.79

Associations between in vivo neuroimaging and postmortem brain cytokine markers in a rodent model of Wernicke's encephalopathy. Exp Neurol (2014) 0.77

Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal models. Pediatr Neurol (2015) 0.76

Pro-inflammatory mediators and apoptosis correlate to rt-PA response in a novel mouse model of thromboembolic stroke. PLoS One (2014) 0.76

MCP-1-induced migration of NT2 neuroprogenitor cells involving APP signaling. Cell Mol Neurobiol (2008) 0.76

Articles by these authors

Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci Res (2004) 1.63

Differential contributions of the basolateral and central nuclei of the amygdala in the negative affective component of chemical somatic and visceral pains in rats. Eur J Neurosci (2003) 1.24

Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice. Behav Brain Res (2005) 1.18

Brain cytokines and chemokines: roles in ischemic injury and pain. J Pharmacol Sci (2006) 1.15

Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice. Neuropsychopharmacology (2004) 1.15

Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Psychopharmacology (Berl) (2003) 1.03

Antagonism of NMDA receptors by sigma receptor ligands attenuates chemical ischemia-induced neuronal death in vitro. Eur J Pharmacol (2002) 1.02

Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn J Pharmacol (2002) 1.02

Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats. Eur J Neurosci (2005) 1.00

Effect of gene transfer of GLT-1, a glutamate transporter, into the locus coeruleus by recombinant adenoviruses on morphine physical dependence in rats. Eur J Neurosci (2004) 0.95

Differential patterns of c-fos mRNA expression in the amygdaloid nuclei induced by chemical somatic and visceral noxious stimuli in rats. Neurosci Lett (2003) 0.93

Involvement of glial glutamate transporters in morphine dependence. Ann N Y Acad Sci (2004) 0.93

Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats. J Pharmacol Exp Ther (2002) 0.93

ATP induces leukemia inhibitory factor mRNA in cultured rat astrocytes. J Neuroimmunol (2002) 0.90

Identification and characterization of novel human Ca(v)2.2 (alpha 1B) calcium channel variants lacking the synaptic protein interaction site. J Neurosci (2002) 0.89

TAK-779, a nonpeptide CC chemokine receptor antagonist, protects the brain against focal cerebral ischemia in mice. J Cereb Blood Flow Metab (2002) 0.84

Effects of excitotoxic lesions of the central or basolateral nucleus of the amygdala on naloxone-precipitated withdrawal-induced conditioned place aversion in morphine-dependent rats. Brain Res (2002) 0.83

Inhibition of glutamatergic transmission by morphine in the basolateral amygdaloid nucleus reduces pain-induced aversion. Neurosci Res (2007) 0.82

Adenosine 5'-triphosphate inhibits slow depolarization induced by repetitive dorsal root stimulation via P2Y purinoceptors in substantia gelatinosa neurons of the adult rat spinal cord slices with the dorsal root attached. Neurosci Lett (2002) 0.82

Excitotoxic injury induces production of monocyte chemoattractant protein-1 in rat cortico-striatal slice cultures. Neurosci Lett (2002) 0.81

Roles of β- and α2-adrenoceptors within the central nucleus of the amygdala in the visceral pain-induced aversion in rats. J Pharmacol Sci (2010) 0.81

Kainic acid induces leukemia inhibitory factor mRNA expression in the rat brain: differences in the time course of mRNA expression between the dentate gyrus and hippocampal CA1/CA3 subfields. Brain Res Mol Brain Res (2002) 0.80

Involvement of locus coeruleus noradrenergic neurons in supraspinal antinociception by alpha,beta-methylene-ATP in rats. J Pharmacol Sci (2004) 0.80

Inhibitory role of supraspinal P2X3/P2X2/3 subtypes on nociception in rats. Mol Pain (2006) 0.79

Facilitation of morphine withdrawal symptoms and morphine-induced conditioned place preference by a glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate in rats. Eur J Pharmacol (2004) 0.79

Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters. Mol Pharmacol (2006) 0.78

(-)-Pentazocine induces visceral chemical antinociception, but not thermal, mechanical, or somatic chemical antinociception, in μ-opioid receptor knockout mice. Mol Pain (2011) 0.78

Role of chemokines in ischemic neuronal stress. Neuromolecular Med (2005) 0.78

Facilitative effect of a glutamate transporter inhibitor (2S,3S)-3-{3-[4-(trifluoromethyl)benzoylamino]benzyloxy}aspartate on the expression of methamphetamine-induced behavioral sensitization in rats. J Pharmacol Sci (2005) 0.76

Abolished thermal and mechanical antinociception but retained visceral chemical antinociception induced by butorphanol in mu-opioid receptor knockout mice. Neuropharmacology (2008) 0.76

[Distinct mechanisms underlying pleasure and analgesia]. Nihon Yakurigaku Zasshi (2005) 0.75

[Roles of the amygdala in pain-related aversive responses]. Nihon Yakurigaku Zasshi (2005) 0.75

Reciprocal regulation of ATPgammaS-induced monocyte chemoattractant protein-1 production by ERK and p38 MAP kinases in rat corticostriatal slice cultures. J Neurosci Res (2009) 0.75